Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35 h later in women at high risk of developing ovarian hyperstimulation syndrome - a prospective randomized double-blind clinical trial

Abstract Background Ovarian hyperstimulation syndrome remains a serious complication during in vitro fertilization cycles if high dose human chorionic gonadotropin (hCG) is used to trigger ovulation in high responder patients. Though much of this risk is mitigated with trigger using gonadotropin rel...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: L. L. Engmann (Autor), B. S. Maslow (Autor), L. A. Kaye (Autor), D. W. Griffin (Autor), A. J. DiLuigi (Autor), D. W. Schmidt (Autor), D. R. Grow (Autor), J. C. Nulsen (Autor), C. A. Benadiva (Autor)
Formato: Libro
Publicado: BMC, 2019-01-01T00:00:00Z.
Materias:
Acceso en línea:Connect to this object online.
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

Connect to this object online.

3rd Floor Main Library

Detalle de Existencias desde 3rd Floor Main Library
Número de Clasificación: A1234.567
Copia 1 Disponible